首页 | 本学科首页   官方微博 | 高级检索  
检索        

吉西他滨联合草酸铂治疗晚期胆管癌的临床观察
引用本文:古伟光,谢忠,廖思海,罗海涛.吉西他滨联合草酸铂治疗晚期胆管癌的临床观察[J].陕西肿瘤医学,2009,17(8):1520-1521.
作者姓名:古伟光  谢忠  廖思海  罗海涛
作者单位:[1]佛山市南海区人民医院肿瘤科,广东佛山528200 [2]广东医学院附属医院肿瘤科,广东湛江524001
摘    要:目的:观察吉西他滨联合草酸铂治疗晚期肝外胆管癌的近期疗效。方法:30例晚期胆管癌患者采用化疗:吉西他滨1000mg/m^2,静脉滴注30~60分钟,第1,8天给药;草酸铂100mg/m^2,静脉滴注2小时,第2天。21天为一个周期。结果:30例中无1例达完全缓解,部分缓解6例(20%),稳定11例(36.7%)。14例(46.7%)患者疼痛得到缓解,生活质量提高。结论:吉西他滨联合草酸铂治疗晚期无法手术的肝外胆管癌具有较好的近期疗效且不良反应可以耐受。

关 键 词:胆管癌  吉西他滨  草酸铂  联合化疗

Therapeutic effect of gemcitabine combined with oxaliplatin in advanced cholangiocarcinoma
Institution:GU Wei - guang , XIE Zhong, LIAO Si - hai, LUO Hai - tao(1 Department of Oncology , Nanhai District People's Hospital, Foshan 528200, China ; 2 Department of Oncology , Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.)
Abstract:Objective:To observe the therapeutic effect of gemeitabine combined with oxaliplatin for the treatment of advanced eholangiocareinoma. Methods:Thirty patients were given gemcitabine and oxaliplatin intravenously. Restilts :There was no complete response. The partial response rate was 20% and SD 36.7% , 14 patients (46.7%) had relic of pain and improvement in quality of life. The toxicity was low and tolerable. Conclusion: Gemcitabine combined with oxaliplatin is an effective and safe regimen for treating advanced eholangiocarcinoma.
Keywords:cholangiocarcinoma  gemcitabine  oxaliplatin  combined chemotherapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号